In a 5‑ft‑4‑in, 215‑lb woman with stage 1 invasive ductal carcinoma on anastrozole, goserelin, propranolol, escitalopram, and omeprazole, who has intermittent eyelid myokymia, occasional lip and knee twitches, chronic leg contour change but no weakness or bulbar signs, are her breathing problems more likely due to obesity rather than amyotrophic lateral sclerosis (ALS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Breathing Problems in This Patient Are Most Likely Due to Obesity, Not ALS

In this 215-lb, 5'4" woman with obesity (BMI ~37 kg/m²) presenting with isolated eyelid myokymia and occasional benign fasciculations but no weakness, bulbar signs, or progressive motor symptoms, her breathing difficulties are almost certainly related to obesity-associated respiratory dysfunction rather than amyotrophic lateral sclerosis.

Clinical Reasoning Against ALS

Benign Nature of Isolated Eyelid Myokymia

  • Chronic isolated eyelid myokymia is a benign condition that does not progress to other neurologic diseases or represent an early manifestation of motor neuron disease 1
  • In a systematic follow-up study of 15 patients with chronic eyelid myokymia (mean symptom duration 91 months), none developed ALS or other neurologic disease 1
  • The presence of occasional lip and knee twitches without weakness or progression does not meet diagnostic criteria for ALS 2, 3

ALS Respiratory Presentation Pattern

  • In ALS, respiratory failure typically occurs late in disease progression and parallels motor weakness 4
  • Respiratory impairment in ALS becomes clinically relevant after loss of ambulation and when upper limb weakness progresses to inability to raise hands to mouth (Brooke score 3) 5
  • Diaphragm involvement preceding locomotor disability occurs in specific ALS variants (acid maltase deficiency, bulbar-onset ALS), but these present with clear motor weakness 6
  • This patient has no documented weakness or bulbar signs, making ALS extremely unlikely 4, 3

Obesity as the Primary Cause of Respiratory Symptoms

Mechanical and Physiologic Effects

  • Obesity causes altered pulmonary function through mechanical interference from excess abdominal fat mass on the chest wall and thoracic cage 7
  • At BMI 37 kg/m², this patient has significant obesity that can directly impair respiratory mechanics 7
  • Obesity is associated with decreased ventilatory response and inadequate respiratory muscle strength to meet increased ventilatory demands 7

Obesity Hypoventilation Syndrome

  • Obesity hypoventilation syndrome (OHS) causes shallow, inefficient breathing and can present with dyspnea 7
  • Symptoms worsen when lying down as abdominal pressure pushes up the diaphragm, reducing respiratory capacity 7
  • OHS is characterized by pCO₂ ≥50 mm Hg in the setting of obesity 7

Obstructive Sleep Apnea

  • Obesity is strongly associated with obstructive sleep apnea (OSA), which causes daytime symptoms including dyspnea 7
  • OSA episodes cause oxygen desaturation and can lead to pulmonary hypertension and cardiopulmonary dysfunction over time 7

Recommended Diagnostic Approach

Immediate Respiratory Assessment

  • Perform pulmonary function tests (PFT) including FVC, TLC, and DLCO to assess baseline respiratory function 8
  • Obtain arterial blood gas to evaluate for hypercapnia (pCO₂ ≥50 mm Hg) suggesting OHS 7
  • Assess for symptoms of sleep-disordered breathing: nocturnal awakenings, daytime sleepiness, morning headaches 9, 5

Sleep Study Evaluation

  • Polysomnography or home sleep study to diagnose OSA, which is highly prevalent in obesity 7
  • Evaluate for nocturnal hypoventilation and oxygen desaturation patterns 9

Exclude Alternative Causes

  • Evaluate for cardiac causes of dyspnea given obesity as cardiovascular risk factor 10, 8
  • Assess for asthma or other primary pulmonary conditions 8

Why ALS Workup Is Not Indicated

Absence of Motor Neuron Disease Features

  • No progressive weakness, muscle atrophy, or functional decline 4, 3, 11
  • No bulbar symptoms (dysarthria, dysphagia) that would suggest motor neuron involvement 4
  • Fasciculations without weakness are common benign findings and do not indicate ALS 1

ALS Diagnostic Criteria Not Met

  • ALS diagnosis requires evidence of both upper and lower motor neuron degeneration with progressive spread 3, 11
  • MRI of brain/spine would be appropriate for suspected motor neuron disease but is not indicated here given absence of motor signs 2

Management Priorities

Address Obesity-Related Respiratory Dysfunction

  • Weight loss is the primary intervention for obesity-related respiratory impairment 7
  • Consider CPAP or BiPAP if OSA or OHS is confirmed 6, 7
  • Controlled oxygen therapy if hypoxemia is present 6

Reassurance Regarding Neurologic Concerns

  • Educate patient that isolated eyelid myokymia with benign fasciculations does not indicate ALS 1
  • No neurologic monitoring or ALS-specific workup is warranted without development of weakness or bulbar signs 2, 3

Common Pitfall to Avoid

  • Do not pursue extensive neurologic workup (EMG, genetic testing, neuroimaging) in the absence of objective motor weakness or progressive functional decline 2, 3
  • Anxiety about ALS can lead to over-investigation of benign fasciculations; focus on the obesity-related respiratory pathology that is clearly present 1

References

Research

Chronic myokymia limited to the eyelid is a benign condition.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2004

Guideline

acr appropriateness criteria® movement disorders and neurodegenerative diseases.

Journal of the American College of Radiology, 2020

Research

Amyotrophic lateral sclerosis.

Lancet (London, England), 2022

Guideline

espen guideline clinical nutrition in neurology.

Clinical Nutrition, 2018

Guideline

respiratory care of the patient with duchenne muscular dystrophy: ats consensus statement.

American Journal of Respiratory and Critical Care Medicine, 2004

Research

Amyotrophic lateral sclerosis: a clinical review.

European journal of neurology, 2020

Related Questions

In a 5‑ft‑4‑in, 215‑lb woman with stage 1 invasive ductal carcinoma on anastrozole, goserelin, propranolol, escitalopram, and omeprazole, with normal labs and imaging, who has intermittent eyelid myokymia, occasional lip twitching, a brief knee twitch, and a longstanding leg contour change but no weakness, atrophy, fasciculations, bulbar symptoms, or functional decline, is evaluation for amyotrophic lateral sclerosis (ALS) necessary?
In a 5‑ft‑4‑in, 215‑lb woman with stage 1 invasive ductal carcinoma on anastrozole, goserelin, propranolol, escitalopram, and omeprazole who has intermittent eyelid myokymia, occasional lip twitching, a brief knee twitch, and a longstanding leg contour change but no weakness, atrophy, bulbar symptoms, or functional decline, is there any reason to be concerned about amyotrophic lateral sclerosis (ALS)?
What is the diagnosis and treatment for a patient presenting with progressive muscle weakness, fasciculations, tremors, and loss of sensation?
Is it worth continuing tamoxifen (Selective Estrogen Receptor Modulator) for 10 years versus 5 years after breast surgery for hormone receptor-positive breast cancer?
Is it necessary to stop Femara (letrozole) after 10 years?
Could escitalopram (Lexapro) and trazodone be causing my urinary urgency and frequency?
What is the best treatment for COVID‑19?
What are the causes of T-wave inversion in leads V2, V3, and V5 in a 62-year-old apparently healthy woman?
In a 5‑ft‑4‑in, 215‑lb woman with stage 1 invasive ductal carcinoma taking anastrozole, goserelin, propranolol, escitalopram, and omeprazole, are occasional knee fasciculations benign and not indicative of a serious neurologic disease?
In an elderly patient with moderate leukocyturia and trace hematuria on urinalysis, presenting with cold-like symptoms, fatigue, increased sleep, and poor appetite, and already prescribed azithromycin for an upper respiratory infection, should I also start an antibiotic for a urinary tract infection?
What is the recommended starting adult dose of metoprolol succinate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.